Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Intern Med ; 62(5): 797-802, 2023 Mar 01.
Article En | MEDLINE | ID: mdl-35945026

Anti-mitochondrial antibody (AMA)-associated myopathies represent a homogeneous disease entity with severe arrhythmia and slowly progressive proximal muscle weakness with lordotic posture, irrespective of the presence of primary biliary cholangitis (PBC). We herein report a case of myositis associated with PBC without AMAs. A 48-year-old woman presented with clinical features very similar to AMA-associated myositis, despite negative AMAs. PBC, ascertained by a liver biopsy performed based on mildly elevated liver enzymes, and the efficacy of steroid therapy on muscle weakness confirmed the diagnosis of immune-mediated myositis. When AMAs are negative, a liver biopsy is indispensable for diagnosing treatable PBC-associated myositis.


Cholangitis , Liver Cirrhosis, Biliary , Myositis , Female , Humans , Middle Aged , Liver Cirrhosis, Biliary/diagnosis , Autoantibodies , Cytarabine , Biopsy
2.
Intern Med ; 60(21): 3477-3480, 2021 Nov 01.
Article En | MEDLINE | ID: mdl-34433712

The clinical characteristics of Guillain-Barré syndrome (GBS) after coronavirus disease 2019 (COVID-19) remain unclear due to the small number of cases. We herein report a case of a Japanese patient with post-COVID-19 GBS who presented with facial and limb muscle weakness, sensory deficits, and autonomic dysfunction. Nerve conduction studies revealed demyelination. Head magnetic resonance imaging showed contrast enhancement in the bilateral facial nerves. Systemic management, including intubation, intravenous immunoglobulin therapy, and rehabilitation, improved the patient's condition. This was the first Japanese case of acute inflammatory demyelinating polyneuropathy after COVID-19 and was characterized by autonomic dysfunction and facial nerve enhancement.


COVID-19 , Guillain-Barre Syndrome , Primary Dysautonomias , Facial Nerve , Guillain-Barre Syndrome/complications , Guillain-Barre Syndrome/diagnosis , Humans , Primary Dysautonomias/etiology , SARS-CoV-2
4.
J Stroke Cerebrovasc Dis ; 28(3): 789-791, 2019 Mar.
Article En | MEDLINE | ID: mdl-30553647

BACKGROUND: Although it was suggested that idiopathic thromobocytopenic purpura (ITP) can be a paradoxical cause of cerebral infarction, previous reports indicate that cerebral infarction associated with ITP occurs when thrombocytopenia is already evident at the onset of cerebral infarction. CASE REPORT: We report a case of multiple cerebral infarction that preceded acute exacerbation of ITP. An 80-year-old woman with a history of ITP presented with tetraplegia, and brain magnetic resonance imaging revealed multiple infarction in bilateral cerebral and cerebellar hemispheres. For ITP, she was treated with oral prednisolone and subcutaneous injection of thrombopoietin receptor agonists. Her platelet count was within the normal range at the onset of cerebral infarction. Medical work-up did not reveal the obvious causes of her multiple cerebral infarction. On day 10 of hospitalization, she showed melena and oral hemorrhage and her platelet count markedly decreased. Her platelet-associated IgG level was elevated and a diagnosis of acute exacerbation of ITP was made. She was treated with intravenous immunoglobulin and her platelet count increased moderately. However, her neurological symptoms and cerebral infarction on magnetic resonance imaging deteriorated accompanied by hemorrhagic transformation. Finally, she died of respiratory failure. CONCLUSIONS: Our case suggests that thrombophilia accompanied by ITP can precede actual exacerbation of ITP and we have to consider ITP as a possible cause of multiple cerebral infarction, even when the platelet count is within the normal range at the onset of cerebral infarction.


Cerebral Infarction/etiology , Purpura, Thrombocytopenic, Idiopathic/complications , Aged, 80 and over , Cerebral Infarction/diagnostic imaging , Diffusion Magnetic Resonance Imaging , Disease Progression , Fatal Outcome , Female , Glucocorticoids/administration & dosage , Humans , Immunoglobulins, Intravenous/administration & dosage , Platelet Count , Purpura, Thrombocytopenic, Idiopathic/blood , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Quadriplegia/etiology , Receptors, Fc/administration & dosage , Recombinant Fusion Proteins/administration & dosage , Risk Factors , Thrombopoietin/administration & dosage
...